BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37890463)

  • 1. Real-world use of antiretroviral therapy and risk of cancer among people with HIV in Texas.
    Horner MJ; Shiels MS; McNeel TS; Monterosso A; Miller P; Pfeiffer RM; Engels EA
    AIDS; 2024 Mar; 38(3):379-386. PubMed ID: 37890463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
    Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
    Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
    Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    ; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
    Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Mukhtar F; Ilozumba M; Utuama O; Cimenler O
    JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
    Silverberg MJ; Lau B; Achenbach CJ; Jing Y; Althoff KN; D'Souza G; Engels EA; Hessol NA; Brooks JT; Burchell AN; Gill MJ; Goedert JJ; Hogg R; Horberg MA; Kirk GD; Kitahata MM; Korthuis PT; Mathews WC; Mayor A; Modur SP; Napravnik S; Novak RM; Patel P; Rachlis AR; Sterling TR; Willig JH; Justice AC; Moore RD; Dubrow R;
    Ann Intern Med; 2015 Oct; 163(7):507-18. PubMed ID: 26436616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
    Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
    J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
    Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.
    van Leeuwen MT; Vajdic CM; Middleton MG; McDonald AM; Law M; Kaldor JM; Grulich AE
    AIDS; 2009 Oct; 23(16):2183-90. PubMed ID: 19734774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
    Castilho JL; Bian A; Jenkins CA; Shepherd BE; Sigel K; Gill MJ; Kitahata MM; Silverberg MJ; Mayor AM; Coburn SB; Wiley D; Achenbach CJ; Marconi VC; Bosch RJ; Horberg MA; Rabkin CS; Napravnik S; Novak RM; Mathews WC; Thorne JE; Sun J; Althoff KN; Moore RD; Sterling TR; Sudenga SL;
    J Natl Cancer Inst; 2022 Jun; 114(6):854-862. PubMed ID: 35292820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Years of life lost to cancer among the United States HIV population, 2006-2015.
    Luo Q; Pfeiffer RM; Noone AM; Horner MJ; Engels EA; Shiels MS
    AIDS; 2022 Jul; 36(9):1279-1286. PubMed ID: 35608110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk following lymphoid malignancies among HIV-infected people.
    Mahale P; Ugoji C; Engels EA; Shiels MS; Peprah S; Morton LM
    AIDS; 2020 Jul; 34(8):1237-1245. PubMed ID: 32287068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
    Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
    Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
    Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
    Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients living with HIV and cancer in Cali, Colombia.
    Parra-Lara LG; Arango-Ibañez JP; Martínez-Arboleda JJ; Bravo JC; Zambrano ÁR; Collazos P; Andino F; Badillo A; Estrada S; Rosso F
    Colomb Med (Cali); 2023; 54(3):e2015558. PubMed ID: 38098512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
    Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR;
    AIDS; 2011 Jul; 25(11):1395-403. PubMed ID: 21572307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
    Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012.
    Wong IKJ; Grulich AE; Poynten IM; Polizzotto MN; van Leeuwen MT; Amin J; McGregor S; Law M; Templeton DJ; Vajdic CM; Jin F
    HIV Med; 2022 Feb; 23(2):134-145. PubMed ID: 34585487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.